Intratumoural drug-delivery gel for pancreatic and lung cancers
| Date | Round | Amount |
|---|---|---|
| Apr 2023 | Seed RCSI spin-out OncoLize raised $1.7m in seed funding led by Libertatis Ergo Holding and Tailored Solutions to expand testing of its intratumoural drug-delivery system. | $1.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.